The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.
The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of Health and Human Services said on ...
Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...
Add articles to your saved list and come back to them any time. Queensland Health has launched an investigation into urology services at Townsville University Hospital, with fears hundreds of patients ...
Researchers at Detroit-based Karmanos Cancer Institute are harnessing robotic technology to accelerate the search for more effective pancreatic cancer treatments for pancreatic cancer, which has one ...
Queensland Health has launched an investigation into urology services at Townsville University Hospital, with fears hundreds of patients have missed critical care and diagnostic testing over a ...
HSV Testing Market Set for Transformative Growth: Opportunities for Manufacturers to Lead Innovation
The expansion of the HSV testing market is being fueled by a combination of increasing prevalence of HSV infections, ...
Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...
A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...
Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s ...
The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback